These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 19342980

  • 1. Usefulness of human telomerase reverse transcriptase in pancreatic juice as a biomarker of pancreatic malignancy.
    Nakashima A, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Oda M, Sueda T, Hiyama E.
    Pancreas; 2009 Jul; 38(5):527-33. PubMed ID: 19342980
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer.
    Ohuchida K, Mizumoto K, Yamada D, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2066-9. PubMed ID: 16609017
    [Abstract] [Full Text] [Related]

  • 7. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
    Shirai Y, Sogawa K, Yamaguchi T, Sudo K, Nakagawa A, Sakai Y, Ishihara T, Sunaga M, Nezu M, Tomonaga T, Miyazaki M, Saisho H, Nomura F.
    Hepatogastroenterology; 2008 Apr 01; 55(86-87):1824-9. PubMed ID: 19102401
    [Abstract] [Full Text] [Related]

  • 8. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
    Yamaguchi T, Shirai Y, Ishihara T, Sudo K, Nakagawa A, Ito H, Miyazaki M, Nomura F, Saisho H.
    Cancer; 2005 Dec 15; 104(12):2830-6. PubMed ID: 16287152
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
    Seki K, Suda T, Aoyagi Y, Sugawara S, Natsui M, Motoyama H, Shirai Y, Sekine T, Kawai H, Mita Y, Waguri N, Kuroiwa T, Igarashi M, Asakura H.
    Clin Cancer Res; 2001 Jul 15; 7(7):1976-81. PubMed ID: 11448913
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K.
    J Clin Gastroenterol; 2006 Oct 15; 40(9):856-62. PubMed ID: 17016145
    [Abstract] [Full Text] [Related]

  • 12. Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings.
    Nodari F, Baiocchi GL, Salvi A, De Petro G, Coniglio A, Ferrari Bravo A, Baronchelli C, Barlati S, Giulini SM.
    Acta Biomed; 2003 Oct 15; 74 Suppl 2():59-64. PubMed ID: 15055037
    [Abstract] [Full Text] [Related]

  • 13. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms.
    Wiesenauer CA, Schmidt CM, Cummings OW, Yiannoutsos CT, Howard TJ, Wiebke EA, Goulet RJ, McHenry L, Sherman S, Lehman GA, Cramer H, Madura JA.
    Arch Surg; 2003 Jun 15; 138(6):610-7; discussion 617-8. PubMed ID: 12799331
    [Abstract] [Full Text] [Related]

  • 14. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
    Hashimoto Y, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T, Shimamoto F, Hiyama E.
    J Surg Oncol; 2008 Apr 01; 97(5):469-75. PubMed ID: 18161862
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Yeh TS, Cheng AJ, Chen TC, Jan YY, Hwang TL, Jeng LB, Chen MF, Wang TC.
    J Surg Res; 1999 Dec 01; 87(2):171-7. PubMed ID: 10600346
    [Abstract] [Full Text] [Related]

  • 17. Analysis of hTERT mRNA expression in biliary tract and pancreatic cancer.
    Kawahara R, Odo M, Kinoshita H, Shirouzu K, Aoyagi S.
    J Hepatobiliary Pancreat Surg; 2007 Dec 01; 14(2):189-93. PubMed ID: 17384912
    [Abstract] [Full Text] [Related]

  • 18. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity.
    Inoue H, Tsuchida A, Kawasaki Y, Fujimoto Y, Yamasaki S, Kajiyama G.
    Cancer; 2001 Jan 01; 91(1):35-41. PubMed ID: 11148557
    [Abstract] [Full Text] [Related]

  • 19. Combination of assay of human telomerase reverse transcriptase mRNA and cytology using bile obtained by endoscopic transpapillary catheterization into the gallbladder for diagnosis of gallbladder carcinoma.
    Uchida N, Tsutsui K, Ezaki T, Fukuma H, Kobara H, Kamata H, Aritomo Y, Masaki T, Watanabe S, Kobayashi S, Nakatsu T, Nakano H, Kuriyama S.
    Am J Gastroenterol; 2003 Nov 01; 98(11):2415-9. PubMed ID: 14638342
    [Abstract] [Full Text] [Related]

  • 20. Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas.
    Aso T, Ohtsuka T, Tamura K, Ideno N, Kono H, Nagayoshi Y, Ohuchida K, Ueda J, Takahata S, Shindo K, Aishima S, Oda Y, Mizumoto K, Tanaka M.
    Pancreas; 2014 Apr 01; 43(3):361-6. PubMed ID: 24622064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.